G904-0130 Screening compound: 4-(3-methyl-4-oxo-4,5,6,7-tetrahydro-1H-indazol-1-yl)-N-(3-methylbutyl)benzamide

G904-0130 Screening compound: 4-(3-methyl-4-oxo-4,5,6,7-tetrahydro-1H-indazol-1-yl)-N-(3-methylbutyl)benzamide
G904-0130 Screening compound: 4-(3-methyl-4-oxo-4,5,6,7-tetrahydro-1H-indazol-1-yl)-N-(3-methylbutyl)benzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound G904-0130
4-(3-methyl-4-oxo-4,5,6,7-tetrahydro-1H-indazol-1-yl)-N-(3-methylbutyl)benzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

G904-0130

Molecular Formula

C20H25N3O2 (C20 H25 N3 O2)

Compound Name

4-(3-methyl-4-oxo-4,5,6,7-tetrahydro-1H-indazol-1-yl)-N-(3-methylbutyl)benzamide

IUPAC name

4-(3-methyl-4-oxo-4567-tetrahydro-1H-indazol-1-yl)-N-(3-methylbutyl)benzamide

SMILES

CC(C)CCNC(c(cc1)ccc1-n1nc(C)c2c1CCCC2=O)=O

InChI

InChI=1S/C20H25N3O2/c1-13(2)11-12-21-20(25)15-7-9-16(10-8-15)23-17-5-4-6-18(24)19(17)14(3)22-23/h7-10,13H,4-6,11-12H2,1-3H3,(H,21,25)

InChI Key

XCHRVNFCRAIACP-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD15074708

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

339.44

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

5

Partition Coefficient, logP

2.761

Distribution Coefficient, logD

2.761

Water Solubility, LogSw

-3.40

Polar Surface Area

52.336

Acid Dissociation Constant (pKa)

12.69

Base Dissociation Constant (pKb)

-1.13

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

45.00

G904-0130 in Drug Discovery

Included in Screening Libraries

3D-Diversity Natural-Product-Like Library (18102 compounds)

Protein Kinases Inhibitors Library (36801 compounds)

Protein-Protein Interaction Library (218420 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Included in 1.7M Stock Database

Structure:
  • 3D
  • Cyclic compounds
Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
Targets:
  • Kinases
Mechanism of action:
  • PPI modulators

References: we are preparing a list of scientific research reports with G904-0130 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound G904-0130?
Check Price and Availability of G904-0130, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of G904-0130 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for G904-0130
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for G904-0130
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of G904-0130 available by request